Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nanne K Kloosterhof

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Lancet. Oncology|July 10, 2010
Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?Nanne K Kloosterhof, Linda B C Bralten, Hendrikus J Dubbink, et al.
Endocrine-Related Cancer|August 30, 2012
Trp53 inactivation leads to earlier phaeochromocytoma formation in pten knockout miceEsther Korpershoek, Nanne K Kloosterhof, Angelique Ziel-van der Made, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2015
Mutation specific functions of EGFR result in a mutation-specific downstream pathway activationLale Erdem-Eraslan, Ya Gao, Nanne K Kloosterhof, et al.
Genes, Chromosomes & Cancer|May 1, 2013
Molecular subtypes of glioma identified by genome-wide methylation profilingNanne K Kloosterhof, Johan J de Rooi, Max Kros, et al.
Genes, Chromosomes & Cancer|March 3, 2010
Integrated genomic profiling identifies candidate genes implicated in glioma-genesis and a novel LEO1-SLC12A1 fusion geneLinda B C Bralten, Nanne K Kloosterhof, Lonneke A M Gravendeel, et al.
Human Mutation|January 16, 2010
Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of gliomaLonneke A M Gravendeel, Nanne K Kloosterhof, Linda B C Bralten, et al.
Acta Neuropathologica|February 24, 2012
Subgroup-specific alternative splicing in medulloblastomaAdrian M Dubuc, A Sorana Morrissy, Nanne K Kloosterhof, et al.
Annals of Neurology|March 30, 2011
IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivoLinda B C Bralten, Nanne K Kloosterhof, Rutger Balvers, et al.
Cancer Research|November 19, 2009
Intrinsic gene expression profiles of gliomas are a better predictor of survival than histologyLonneke A M Gravendeel, Mathilde C M Kouwenhoven, Olivier Gevaert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Lancet. Oncology|July 10, 2010
Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?Nanne K Kloosterhof, Linda B C Bralten, Hendrikus J Dubbink, et al.
Endocrine-Related Cancer|August 30, 2012
Trp53 inactivation leads to earlier phaeochromocytoma formation in pten knockout miceEsther Korpershoek, Nanne K Kloosterhof, Angelique Ziel-van der Made, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2015
Mutation specific functions of EGFR result in a mutation-specific downstream pathway activationLale Erdem-Eraslan, Ya Gao, Nanne K Kloosterhof, et al.
Genes, Chromosomes & Cancer|May 1, 2013
Molecular subtypes of glioma identified by genome-wide methylation profilingNanne K Kloosterhof, Johan J de Rooi, Max Kros, et al.
Genes, Chromosomes & Cancer|March 3, 2010
Integrated genomic profiling identifies candidate genes implicated in glioma-genesis and a novel LEO1-SLC12A1 fusion geneLinda B C Bralten, Nanne K Kloosterhof, Lonneke A M Gravendeel, et al.
Human Mutation|January 16, 2010
Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of gliomaLonneke A M Gravendeel, Nanne K Kloosterhof, Linda B C Bralten, et al.
Acta Neuropathologica|February 24, 2012
Subgroup-specific alternative splicing in medulloblastomaAdrian M Dubuc, A Sorana Morrissy, Nanne K Kloosterhof, et al.
Annals of Neurology|March 30, 2011
IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivoLinda B C Bralten, Nanne K Kloosterhof, Rutger Balvers, et al.
Cancer Research|November 19, 2009
Intrinsic gene expression profiles of gliomas are a better predictor of survival than histologyLonneke A M Gravendeel, Mathilde C M Kouwenhoven, Olivier Gevaert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Pageof 2